Artificial intelligence, digital health and novel therapeutic technologies are expected to drive transformation in biopharma in 2024, despite ongoing challenges in financing.
20 Voices: What Does 2024 Hold For Biopharma?
Executive Predictions From Deals And Money To Tech And Trials
20 executives in the biopharma industry outline their view of key trends this year. A selection of commentary from a broad industry survey by Scrip.
